4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Apotex Health Corp. (APTX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Toronto, Canada with about 6,000 employees. Its market capitalization is roughly CAD 8 billion. In the fiscal year ended 2026-03-31, APTX reported CAD 3.5B in revenue and CAD 374M in net income.
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Total Revenue | CAD 3.5B | CAD 3.3B | CAD 2.9B |
| Gross Profit | CAD 1.9B | CAD 1.8B | CAD 1.1B |
| Operating Income (EBIT) | CAD 1.0B | CAD 766M | CAD 194M |
| Net Income | CAD 374M | CAD 152M | (CAD 147M) |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Dividends Paid | (CAD 1.1B) | (CAD 164M) | CAD 0M |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Total Assets | CAD 4.5B | CAD 4.9B | CAD 4.0B |
| Total Liabilities | CAD 5.1B | CAD 4.6B | CAD 3.3B |
CAD; CADM / CADB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APTX viewer.
About TickerBase · Data methodology & sources · Privacy · Terms